According to a market report by Lucintel, the future of the global needle free injection system market looks promising with opportunities in the vaccine needle-free delivery, insulin needle-free delivery, pain management needle-free delivery, and oncology needle-free delivery markets. The global needle free injection system market is expected to reach an estimated $5 billion by 2035 with a CAGR of 5.1% from 2026 to 2035. The major drivers for this market are the rising adoption of needle-free technology in medical practices, the growing demand for home care services & self-administered injections, and the increasing demand for preference for painless injections among patients.
A more
than 150-page report to understand trends, opportunity and forecast in global needle
free injection system market to 2035 by type of medication (liquid-based
needle-free injectors, powder-based needle-free injectors, and
projectile/depot-based needle-free injectors), product (fillable needle-free
injectors and prefilled needle-free injectors), site of delivery (intradermal
injectors, intramuscular injectors, and subcutaneous injectors), application
(vaccine needle-free delivery, insulin needle-free delivery, pain management
needle-free delivery, oncology needle-free delivery, and others), and region
(North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type of medication category, liquid-based
needle-free injector is expected to witness the highest growth over the
forecast period due to the easier drug delivery and patient comfort benefits.
Within the
application category, vaccine needle-free delivery is expected to witness the
highest growth due to the rising immunization programs and vaccine demand.
Download
sample by clicking on needle
free injection system market.
In terms
of regions, APAC is expected to witness the highest growth over the forecast
period due to the expanding healthcare infrastructure and vaccination
initiatives.
Endo
International plc, Ferring Pharmaceuticals, Penjet Corporation, Medical
International Technology Inc., PharmaJet are the major suppliers in the needle free injection system market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment